Title |
Epidemia da AIDS e a Sociedade Moçambicana de Medicamentos: análise da cooperação brasileira
|
---|---|
Published in |
Ciência & Saúde Coletiva, July 2017
|
DOI | 10.1590/1413-81232017227.03892017 |
Pubmed ID | |
Authors |
Maíra da Silva Fedatto |
Abstract |
This article analyzes the Brazilian South South Cooperation in Health in Mozambique, specifically the fight against the AIDS Epidemic through the Antiretroviral Factory, in light of the concept of Structural Cooperation in Health, and with a basis in the literature on Cooperation for Development and Global Health. Thus, the article is divided into four parts: (i) a historical-bibliographic review of health as an International Relations issue; (ii) an overview of the field of health in Mozambique; (iii) an historical-political-conceptual debate about both types of International Cooperation for Development: North-South Cooperation and South-South Cooperation; (iv) a study about the antiretroviral factory, better known as the Mozambican Society of Medicines (Sociedade Moçambicana de Medicamentos). Through a case study, our goal is to verify if the Brazilian actions in Mozambique are in accordance with the concepts defended by the Structural Cooperation in Health, as well as to create new inquiries for academic debate. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 1 | 25% |
United Kingdom | 1 | 25% |
United States | 1 | 25% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 2 | 50% |
Members of the public | 2 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 2 | 11% |
Student > Ph. D. Student | 2 | 11% |
Researcher | 2 | 11% |
Student > Master | 2 | 11% |
Student > Doctoral Student | 1 | 5% |
Other | 3 | 16% |
Unknown | 7 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Social Sciences | 5 | 26% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Immunology and Microbiology | 1 | 5% |
Business, Management and Accounting | 1 | 5% |
Economics, Econometrics and Finance | 1 | 5% |
Other | 1 | 5% |
Unknown | 9 | 47% |